Isosulfan blue 1% vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFBT5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,862
Award facts
- Contract value 100% obligated
- $14,861.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $14,861.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Isosulfan Blue 1% in 5mL vials. The delivery order, issued on December 30, 2025, with an ultimate completion date of December 31, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, that positions the company as a critical pharmaceutical supplier for Department of Defense healthcare operations globally.
The PPV-G GEN V represents a component of the broader $30.3 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial federal contracting activity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, supplying an extensive portfolio encompassing branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's established performance across multiple therapeutic categories and product lines supports its role as a primary distributor within the federal military pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FFBT5?
SPE2DR26FFBT5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FFBT5 worth?
The government has obligated $14,862 on SPE2DR26FFBT5.
Is contract SPE2DR26FFBT5 an order under another contract?
Yes. SPE2DR26FFBT5 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBT5 competed?
The extent of competition for SPE2DR26FFBT5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award